Charles Hugh-Jones

Charles Hugh-Jones is the current Chief Executive Officer at Volastra. Charles has also served as the Global Chief Medical Officer at Allergan from August 2018 to July 2020, and as the Chief Medical Officer, Pfizer Oncology from May 2017 to July 2018. Before that, they were the Regional Medical Officer at Sanofi North America from July 2010 to July 2016.

Charles Hugh-Jones has a MD from the University of London, and is Board Certified in Internal Medicine with higher specialist training in Diagnostic Radiology. Charles also has a Bachelors in Neuroanatomy from the University of London. Charles is certified by the Royal College of Physicians in Fellowship of Royal College of Physicians (FRCP), Primary Fellowship (FRCR I), and Membership Royal College of Physicians (MRCP).

Michael Arensman - Senior Scientist, Biology, Yazen Jmeian - Director, Bio-therapeutics, and Rumin Zhang - VP, Biochemistry report to Charles Hugh-Jones.